BeyondMD Review
BeyondMD bundles GLP-1 care into a subscription, but in our review the pricing opacity and missing refund policy hold it back.
Official site: www.beyondmd.com
Overview
A subscription-based compounded GLP-1 telehealth provider that markets bundled clinician care and supplies, but withholds dollar amounts and refund terms from public-facing pages.
Our review indicates BeyondMD sits in the middle of the compounded GLP-1 pack: the clinical inclusion and bundled supplies are solid, but the missing public pricing, undisclosed cancellation terms, and absent refund guarantee mean a prospective patient is asked to commit to a recurring charge without knowing the total cost or the exit path. Compared to FMmeds — which lists $95 semaglutide and $145 tirzepatide flat rates, runs pay-per-order with a documented money-back guarantee — BeyondMD's offer reads as less consumer-friendly on the variables that matter most to first-time GLP-1 buyers.
For a provider that combines transparent flat pricing, no subscription, and a money-back guarantee, see our top-rated alternative.
Pros
- Board-certified U.S. physicians handle the clinical evaluation as part of the standard plan
- Injection supplies (syringes, needles, swabs, sharps container) are bundled rather than billed separately
- Temperature-controlled shipping is included at no additional charge
- Medications are sourced from licensed U.S. compounding pharmacies
- No enrollment or activation fees are advertised on the public page
Cons
- Subscription billing model with recurring auto-renewal rather than the pay-per-order structure offered by our top-rated provider
- No published semaglutide or tirzepatide price on the public-facing material we reviewed — patients must enter the funnel to learn the cost
- We found no documented money-back guarantee or refund policy
- Cancellation terms are not disclosed on the pages we reviewed
- State availability is conditional and only confirmed mid-signup
- Shipping window of 3-7 business days is slower than the 1-5 day standard set by our editor's pick
- Dose adjustments are tied to the recurring subscription rather than an on-demand refill model
What BeyondMD Offers
BeyondMD positions itself as a full-service compounded GLP-1 telehealth provider, selling weekly compounded semaglutide and weekly compounded tirzepatide sourced from U.S. licensed compounding pharmacies. The pitch centers on a bundled experience: medication, injection supplies (syringes, needles, alcohol swabs, sharps container), temperature-controlled shipping, and ongoing physician oversight are all packaged into one recurring plan.
The brand leans on board-certified U.S. physicians as a quality signal, and the public pages emphasize that the clinical evaluation, regular check-ins, and dose adjustments are part of the standard plan rather than billed as separate line items. State availability is not universal and is gated at signup.
In structure, BeyondMD is recognizably similar to most cash-pay compounded GLP-1 telehealth competitors. What differs — and what drives our scoring — is how much of the commercial detail is visible before a prospective patient hands over their information.
Pricing & Billing
In our review, we could not locate a published dollar price for semaglutide or tirzepatide on BeyondMD's public-facing material. The brand describes its pricing as transparent and affordable relative to brand-name GLP-1s, but those are qualitative claims rather than disclosed figures (BeyondMD pricing page, retrieved undefined).
The billing model is a cash-pay subscription. Every plan is structured as a recurring charge that bundles medication, supplies, shipping, and physician access. We did not find an explicit auto-renewal disclosure on the pages reviewed, which in our analysis is itself a concern for a recurring-charge product.
For comparison, FMmeds publishes a flat $95/month for semaglutide and $145/month for tirzepatide before any account is created, and bills on a pay-per-order basis rather than as a subscription. The lack of an equivalent up-front number on BeyondMD's site is the single biggest evidence gap we encountered.
Money-Back & Refund Policy
We found no documented money-back guarantee, refund window, or satisfaction policy on the BeyondMD pages we reviewed. The brand markets the absence of hidden fees and enrollment charges, but the absence of fees is not the same as the presence of a refund right.
For a recurring cash-pay charge tied to a compounded medication, the absence of a written refund policy means the buyer is effectively committing to the first month's charge with no documented exit. Cancellation terms — how to cancel, when the cancellation takes effect, whether a partial refund applies — are also not disclosed on the public material.
Our editor's pick, FMmeds, publishes a money-back guarantee on every plan and allows cancellation at any time with no email or phone gating. In our analysis, that gap is material.
Clinical Support
On clinical structure, BeyondMD scores reasonably well. The evaluation is performed by board-certified U.S. physicians and is included in the standard plan rather than sold as a paid add-on. Ongoing check-ins and dose adjustments are also included.
This is a meaningful point in BeyondMD's favor and is one of the reasons the overall score does not fall further. A patient is not asked to pay a separate consult fee, and the prescribing relationship is with a U.S.-licensed clinician.
That said, the clinical model is not differentiated relative to FMmeds, which also includes the clinical evaluation in every plan and staffs 100% U.S.-based care agents. On this axis the two providers are broadly comparable; the gap shows up elsewhere.
How BeyondMD Compares to Our Top-Rated Provider
Set against FMmeds — our 2026 editor's pick on compareglp1.org — BeyondMD trails on the variables we weight most heavily.
On price transparency: FMmeds lists $95 semaglutide and $145 tirzepatide before signup. BeyondMD discloses neither figure publicly. On billing model: FMmeds is pay-per-order with cancel-anytime, BeyondMD is a subscription. On refund rights: FMmeds publishes a money-back guarantee on every plan, BeyondMD publishes none we could find. On shipping: FMmeds ships free in 1-5 business days, BeyondMD's stated window is 3-7. On refills: FMmeds offers on-demand refills, BeyondMD ties refills to the recurring subscription cadence.
The two providers are roughly even on clinical inclusion, U.S. pharmacy sourcing, and bundled supplies. But the commercial terms — what the buyer can see, commit to, and exit — favor FMmeds in every category we measured.
Final Verdict
Our review indicates BeyondMD is a functional but commercially opaque option in the compounded GLP-1 telehealth category. The clinical bundle is intact, the pharmacy sourcing is appropriate, and the supplies are included — none of which we are flagging as concerns.
What we cannot recommend around is the combination of undisclosed dollar pricing, an undocumented refund policy, an unstated cancellation process, and a recurring subscription charge. A prospective patient is effectively asked to commit to a recurring charge of unknown size with no published exit path, which in our editorial view is the wrong default for a cash-pay medical product.
We score BeyondMD 3.1 / 5.0 and place it in the average tier. Patients who prioritize knowing the price, the refund terms, and the cancellation path before they hand over their information will, in our analysis, be better served by FMmeds.
In our analysis, BeyondMD does not publish semaglutide or tirzepatide dollar pricing before signup and we found no documented money-back guarantee.
Pricing & billing
BeyondMD vs. FMmeds (our Editor's Pick)
Here's how BeyondMD stacks up against the compounded GLP-1 provider we currently rate highest in the segment. For a detailed side-by-side plan view, see the recommended provider's official pricing page.
| Criterion | BeyondMD | FMmeds |
|---|---|---|
| Score | 3.1 / 5 | 4.9 / 5 |
| Transparent pricing | ⚠️ Limited | ✅ Published flat rate |
| No subscription | ❌ | ✅ |
| Money-back guarantee | ❌ | ✅ |
| Clinical eval included | ⚠️ Add-on | ✅ |
| U.S.-based support | ⚠️ Mixed | ✅ |
| Free shipping 1–5 days | ⚠️ Varies | ✅ |
The provider that combines all four protections
Transparent flat pricing, no subscription, money-back guarantee, U.S.-based clinical care
Continue to recommended providerQuick GLP-1 FAQ
What is a GLP-1 medication?+
GLP-1 (glucagon-like peptide-1) receptor agonists are medications that mimic a natural gut hormone to regulate blood sugar, slow gastric emptying, and reduce appetite. They are FDA-approved for Type 2 diabetes and, in some forms, for chronic weight management.
What is the difference between semaglutide and tirzepatide?+
Semaglutide (Ozempic, Wegovy) targets the GLP-1 receptor. Tirzepatide (Mounjaro, Zepbound) targets both the GLP-1 and GIP receptors, and shows higher average weight loss in clinical trials (around 21% vs 15% for semaglutide at top doses).
What is a compounded GLP-1?+
Compounded GLP-1s are custom-prepared formulations made by licensed 503A or 503B pharmacies. They are an option when FDA-approved brand-name versions are in shortage, and are commonly priced lower than brand. Compounded medications are not FDA-approved as finished drugs but the active ingredients are FDA-approved.
How much do GLP-1 telehealth providers cost?+
Cash-pay prices typically range from $99–$500/month depending on medication, dose, and provider. Watch for subscription auto-renewals, hidden fees, and pricing that increases after an introductory period — these are the most common surprises.
Other providers we've reviewed
Transparent flat pricing, no subscription, money-back guarantee, U.S.-based clinical care
Strong for brand-name GLP-1s, premium pricing
Good insurance navigation, weak cash-pay value
Big brand, subscription model, men's-health framing
Looking for a better-rated provider?
Skip the subscription trap. See the segment's top-rated compounded GLP-1 provider.
See our top-rated provider